THYROID CALCIFICATION

This adverse event was reported 66 times

These drugs are most commonly taken by patients reporting THYROID CALCIFICATION:

# Drug Count
0 FULVESTRANT 8
1 PALBOCICLIB 8
2 ADALIMUMAB 7
3 DENOSUMAB 5
4 ERGOCALCIFEROL 5
5 METHOTREXATE SODIUM 5
6 METHADONE 4
7 METHOTREXATE 4
8 METOCLOPRAMIDE 4
9 METOCLOPRAMIDE HYDROCHLORIDE 4
See all common drugs associated with THYROID CALCIFICATION

THYROID CALCIFICATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM IODIDE I 123 1 0.0011
1 SODIUM IODIDE I 131 1 0.0010
2 BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES 1 0.0006
3 CERITINIB 1 0.0004
4 SULINDAC 1 0.0004
5 AMIFAMPRIDINE PHOSPHATE 1 0.0003
6 DONANEMAB-AZBT 1 0.0003
7 CALCITONIN SALMON 1 0.0003
8 ACETAMINOPHEN AND DIPHENHYDRAMINE HCL 1 0.0003
9 FULVESTRANT 8 0.0002
See all drugs enriched for association with THYROID CALCIFICATION

THYROID CALCIFICATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin [EPC] 1 0.0003
1 Estrogen Receptor Antagonist [EPC] 8 0.0002
2 Provitamin D2 Compound [EPC] 5 0.0002
3 Glinide [EPC] 1 0.0001
4 Interleukin-17A Antagonist [EPC] 4 0.0001
5 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
6 Barbiturate [EPC] 1 0.0001
7 GLP-2 Analog [EPC] 1 0.0001
8 Stimulant Laxative [EPC] 1 0.0001
9 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
See all drug classes enriched for association with THYROID CALCIFICATION